A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  J. Rhim,et al.  MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1 , 2014, Oncotarget.

[3]  T. Patel,et al.  Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma. , 2014, Gene expression.

[4]  R. Brunelli,et al.  Cholangiocarcinoma: increasing burden of classifications. , 2013, Hepatobiliary surgery and nutrition.

[5]  D. Iliopoulos,et al.  miRNAs link metabolic reprogramming to oncogenesis , 2013, Trends in Endocrinology & Metabolism.

[6]  T. Jiang,et al.  MiR-410 regulates MET to influence the proliferation and invasion of glioma. , 2012, The international journal of biochemistry & cell biology.

[7]  T. Roskams,et al.  Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes , 2012, Hepatology.

[8]  Kevin Struhl,et al.  An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis , 2011, Cell.

[9]  B. Job,et al.  Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma , 2011, British Journal of Cancer.

[10]  G. Salles,et al.  Cyclin-dependent kinase 1 expression is inhibited by p16INK4a at the post-transcriptional level through the microRNA pathway , 2011, Oncogene.

[11]  G. Gores,et al.  Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on. , 2011, Journal of hepatology.

[12]  Zhijian J. Chen,et al.  ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. , 2010, Molecular cell.

[13]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[14]  S. Okada,et al.  Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF‐κB , 2010, Cancer science.

[15]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[16]  G. Gores,et al.  MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 , 2009, Hepatology.

[17]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[18]  S. Baird,et al.  IAP-targeted therapies for cancer , 2008, Oncogene.

[19]  J. Stenvang,et al.  The utility of LNA in microRNA-based cancer diagnostics and therapeutics. , 2008, Seminars in cancer biology.

[20]  G. Gores,et al.  mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.

[21]  Jiahuai Han,et al.  XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. , 2007, Molecular cell.

[22]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[23]  G. Gores,et al.  Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. , 2005, Gastroenterology.

[24]  V. Dragowska,et al.  Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[26]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[27]  Y. Sheng,et al.  Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. , 2000, Cancer research.

[28]  W. Zong,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .

[29]  Christian Stehlik,et al.  Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.

[30]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[31]  D. Berry,et al.  Prognostic molecular markers in cholangiocarcinoma: a systematic review. , 2009, European journal of cancer.

[32]  L. Tian,et al.  Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation. , 2003, Oncology research.

[33]  V. Bilim,et al.  Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug‐resistant TCC in vitro , 2003, International journal of cancer.